| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.16 | 0.007 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.11 | 0.06 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.092 | 0.1 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.088 | 0.1 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.092 | 0.1 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.068 | 0.3 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.056 | 0.4 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.049 | 0.4 |